A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
2011 Legislative Outlook Important for Rheumatology
Next year is shaping up to be an important year for rheumatology on Capitol Hill. Issues that remain unresolved by the last Congress include concerns within the Affordable Care Act, the need for a stable Medicare system with fair physician reimbursement, funding for the pediatric subspecialty loan repayment program, and appropriate reimbursement for specialty care. Most congressional leaders, newly elected or re-elected, know very little about arthritis and other rheumatic diseases. That is why it is critical that rheumatology professionals reach out and educate them on the importance of specialty care and the impact these diseases have on one’s quality of life.
Rheum with a View
Panush’s perspectives on selections from the literature
“A Common Language for Spondyloarthritis”
ASAS fills a niche, changes dogma with consensus approach
Arthritis on the Rise
CDC notes significant increase in arthritis-attributable activity limitation
For Myopathy Basic Diagnostic Rules Hold
Rare and challenging, idiopathic inflammatory myopathies are gaining from collaborative research
On the Edge with Medicare: Will Cuts Drive Rheumatologists to Opt Out?
Will cuts drive rheumatologists to opt out?
Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media
There’s no question that direct-to-consumer (DTC) advertising of prescription drugs is a huge activity, with nearly $5 billion spent on DTC ads in 2007. There’s also no question that the Internet has a vast potential to reach consumers. But when you put DTC advertising and the Internet together, there is a potential for problems and…
DEXA Champion Visits Local Rheumatologist
Sen. Blanche Lincoln (D-Ark.) visited the Arthritis Center of the Ozarks in Fayetteville, Ark., in August to speak with local rheumatologist Michael Saitta, MD, to discuss the importance of access to osteoporosis screenings.
Research Tracks Possible Benefit of Src-like Adaptor Protein
A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.
- « Previous Page
- 1
- …
- 215
- 216
- 217
- 218
- 219
- …
- 246
- Next Page »